Clinical Study of Improved Minimally Invasive Hematoma Aspiration in the Treatment of Cerebral Hemorrhage

Objective To investigate the clinical effect of improved minimally invasive hematoma aspiration in the treatment of cerebral hemorrhage. Methods 202 cases with cerebral hemorrhage admitted in our hospital from January 2011 to February 2015 were selected as the subjects and equally divided into the treatment group and the control group with 101 cases in each. Patients in the control group were given the clinical conventional minimally invasive hematoma aspiration, and those in the treatment group were treated by minimally invasive hematoma aspiration improved by our hospital. And the efficacy was compared between the two groups. Results The first aspiration volume was 14.3m L in the treatment group, and 26.7m L in the control group, the Barthel score was 89.4 points in the treatment group, and that was 65.2 points in the control group.The prognosis of the treatment group was much better than that of the control group with statistically significant difference,P0.01. In the treatment group, 12 cases had rebleeding, 5 cases died, in the control group, 31 cases had rebleeding, 19 cases died, the difference between the two groups was statistically significant(P0.01). Conclusion Improved minimally invasive hematoma aspiration is an effective surgical treatment for cerebral hemorrhage with significant effect, so it is worthy of extensive promotion and in-depth study.